SecBot SecBot
Insider Cluster (2 insiders) ·Filed Oct 23, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 11h ago
Insider cluster: 2 insiders, $473K total
Actionable Insight • Neutral

This insider cluster is routine and non-informative. The CEO's sales follow a standard option-exercise pattern, and the dollar amount is trivial relative to market cap. No trading action warranted. Monitor next 10-Q for any fundamental changes.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt sold ~$5.5M in open-market shares on October 22, 2026, following an option exercise, while EVP & General Counsel Paul Mahon sold $431K on October 15. The CEO's sales are part of a routine pattern tied to derivative exercises and tax withholding, not a bearish signal. Total open-market sales of ~$5.9M represent 0.02% of UTHR's $24.2B market cap — trivial and non-informative. The cluster is neutral.

Key Financial Metrics

Direction
selling
Total Value
$5.9M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold ~$5.5M in open-market shares on Oct 22, 2026, across 19 trades at prices $562.97-$590.40.
  • CEO also exercised 9,500 derivative shares at $0 (non-cash) on the same day, a typical prelude to sell-to-cover for tax obligations.
  • EVP & General Counsel Paul Mahon sold 791 shares at $544.85 for $431K on Oct 15, 2026.
  • Total open-market sales of ~$5.9M represent 0.02% of UTHR's $24.2B market cap — well below the 0.1% materiality threshold.
  • Recent 30-day insider activity shows 9 sells totaling $3.7M, consistent with routine portfolio diversification.

Financial Impact

Total open-market sales of ~$5.9M, or 0.02% of market cap — immaterial.

insider selling volume

Risk Factors

  • CEO sales could be misinterpreted as bearish by retail traders, creating short-term noise.
  • If future filings reveal a material negative catalyst (e.g., FDA setback, trial failure), the pattern of insider selling would gain significance retroactively.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1792790125147
111 reports for UTHR
Performance horizon
50% Hit rate @ T+5 4 of 8 directional calls Went positive at some point 5 of 9 best @ T+60▲ +9.62%Apr 16, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
Insider Cluster
NEUTRAL ★ 2/10
$587.50awaiting T+5—$592.84 (+0.91%)
Oct 22, 2026
4d ago
8-K
NEUTRAL ★ 4/10
$584.79awaiting T+5—$592.84 (+1.38%)
Oct 22, 2026
5d ago
Insider Cluster
BEARISH ★ 4/10
$587.50awaiting T+5—$592.84 (−0.91%)
Oct 21, 2026
5d ago
Insider Cluster
NEUTRAL ★ 3/10
$584.79awaiting T+5—$592.84 (+1.38%)
Oct 20, 2026
6d ago
Insider Cluster
NEUTRAL ★ 2/10
$563.49awaiting T+5—$592.84 (+5.21%)
Oct 19, 2026
8d ago
Insider Cluster
NEUTRAL ★ 3/10
$553.88awaiting T+5—$592.84 (+7.03%)
Oct 16, 2026
10d ago
Insider Cluster
NEUTRAL ★ 3/10
$543.15 $592.84▲ +9.15%▲ +9.29%$592.84 (+9.15%)
Oct 14, 2026
12d ago
8-K
BULLISH ★ 7/10
$540.03 $563.49▲ +4.34%▲ +3.89%$592.84 (+9.78%)
Oct 5, 2026
21d ago
Insider Cluster
BEARISH ★ 5/10
$541.62 $543.40▼ −0.33%▼ −0.47%$592.84 (−9.46%)
Oct 2, 2026
24d ago
Insider Cluster
NEUTRAL ★ 3/10
$536.40 $550.10▲ +2.55%▲ +2.13%$592.84 (+10.52%)
Showing 10 of 111

US Market Status

Market Closed — Opens in 4h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 23, 2026